Product Information
KENALOG-40 40 MG/ML VIAL is a brand product labeled by E.R. Squibb & Sons, L.L.C., priced at $9.0018 per ML under NDC 00003029305. Its NADAC has been published 615 times since Nov 28, 2013.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/mL
Manufacturer
E.R. Squibb & Sons, L.L.C.NDC
00003029305
Classification
Brand
Dosage Form
INJECTION, SUSPENSION
Route
INTRA-ARTICULAR; INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
New Drug (NDA)
FDA Application
NDA014901FDA Approved
Before 1982
TE Code
AB
On Market Since
6/1/2009
Pharmacological Classes
Price Statistics
The NADAC for KENALOG-40 40 MG/ML VIAL has been published 615 times since Nov 28, 2013, and over the history we have for it it has risen 9.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0018 per ML |
|---|---|
| All-time high | $9.0496 (Oct 15, 2025) |
| All-time low | $8.1964 (Mar 23, 2016) |
| 52-week high | $9.0496 |
| 52-week low | $9.0007 |
| Median price | $8.9567 |
| Average price | $8.7662 |
| Largest weekly change | +6.0% (Jan 11, 2017) |
| Weeks tracked | 615 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 46% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
E.R. Squibb & Sons, L.L.C. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TRIAMCINOLONE ACETONIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KENALOG-40 40 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KENALOG-40 40 MG/ML VIAL, manufactured by E.R. Squibb & Sons, L.L.C., is $9.0018 per ML (NDC 00003029305), effective Sep 30, 2026.
How has the price of KENALOG-40 40 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for KENALOG-40 40 MG/ML VIAL has risen 9.1%. It has been tracked across 615 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KENALOG-40 40 MG/ML VIAL?
Since Nov 28, 2013, the NADAC for KENALOG-40 40 MG/ML VIAL has ranged from a low of $8.1964 (Mar 23, 2016) to a high of $9.0496 (Oct 15, 2025), with a median of $8.9567 per ML.
Are there cheaper alternatives to KENALOG-40 40 MG/ML VIAL?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRIAMCINOLONE ACET 40 MG/ML VL, is $4.8304 per ML — about 46% below KENALOG-40 40 MG/ML VIAL.
Who manufactures KENALOG-40 40 MG/ML VIAL?
KENALOG-40 40 MG/ML VIAL (NDC 00003029305) is labeled by E.R. Squibb & Sons, L.L.C., and CMS classifies it as a brand product.